Wwox-Brca1 interaction: role in DNA repair pathway choice

Area of Science:

• Molecular Biology
• Genetics
• Cancer Research

Background:

• Reduced Wwox protein expression is observed in various human cancers and linked to poor prognosis.
• WWOX gene deletions and loss of Wwox protein expression are early events in cancer development.
• Wwox deficiency can lead to chromosome instability and resistance to DNA-damaging agents.

Purpose of the Study:

• To investigate the role of Wwox protein in cellular response to DNA damage and cancer treatment.
• To elucidate the mechanisms by which Wwox loss affects DNA double-strand break (DSB) repair pathways.
• To determine the clinical significance of Wwox expression in cancer patient outcomes.

Main Methods:

• Utilized Wwox-knockout mouse embryo fibroblast cells and human cancer cell lines.
• Assessed cell survival following exposure to ionizing radiation and bleomycin.
• Analyzed DNA double-strand break repair pathway choice (homology-directed repair and non-homologous end-joining) using molecular techniques.
• Investigated protein interactions (Wwox with Brca1 and Rad51) and DNA repair foci formation.

Main Results:

• Wwox-deficient cells showed enhanced survival after ionizing radiation and bleomycin treatment.
• Wwox loss led to increased homology-directed repair (HDR) and decreased non-homologous end-joining (NHEJ).
• Silencing Rad51 resensitized Wwox-deficient cells to radiation, and Wwox interacts with Brca1 to suppress HDR.
• Wwox deficiency in cancer patients correlated with shorter overall survival after radiation therapy.

Conclusions:

• Wwox acts as a genome caretaker by promoting NHEJ as the dominant DSB repair pathway.
• Loss of Wwox dysregulates DNA DSB repair, favoring mutagenic repair pathways.
• Reduced Wwox expression contributes to therapeutic resistance and poor outcomes in cancer patients, highlighting WWOX as a potential therapeutic target.